Cite
Zimmer M, Bista P, Benson EL, et al. CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice. Hepatol Commun. 2017;1(4):311-325doi: 10.1002/hep4.1042.
Zimmer, M., Bista, P., Benson, E. L., Lee, D. Y., Liu, F., Picarella, D., Vega, R. B., Vu, C. B., Yeager, M., Ding, M., Liang, G., Horton, J. D., Kleemann, R., Kooistra, T., Morrison, M. C., Wielinga, P. Y., Milne, J. C., Jirousek, M. R., & Nichols, A. J. (2017). CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice. Hepatology communications, 1(4), 311-325. https://doi.org/10.1002/hep4.1042
Zimmer, Michael, et al. "CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice." Hepatology communications vol. 1,4 (2017): 311-325. doi: https://doi.org/10.1002/hep4.1042
Zimmer M, Bista P, Benson EL, Lee DY, Liu F, Picarella D, Vega RB, Vu CB, Yeager M, Ding M, Liang G, Horton JD, Kleemann R, Kooistra T, Morrison MC, Wielinga PY, Milne JC, Jirousek MR, Nichols AJ. CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice. Hepatol Commun. 2017 May 12;1(4):311-325. doi: 10.1002/hep4.1042. eCollection 2017 Jun. PMID: 29404461; PMCID: PMC5721391.
Copy
Download .nbib